EPISODE · Aug 29, 2025 · 4 MIN
VC가 한발 물러설 때 바이오 기업의 대체 자금원은? (Korean-language podcast)
from Citeline Podcasts · host Norstella
전통적 벤처캐피털이 점점 더 신중하고 선별적인 투자 성향으로 변하면서 바이오 기업들이 새로운 자본 조달 경로를 모색하고 있다는 Citeline의 In Vivo 기사를 요약한 내용입니다. https://insights.citeline.com/in-vivo/growth/when-vc-steps-back-finding-alternative-biotech-funding-4UN5IYJEUZD2XPLYIZ7RR7YVQY/ Playlist: https://soundcloud.com/citelinesounds/sets/korean-language-biopharma-mini
Embed this episode
NOW PLAYING
VC가 한발 물러설 때 바이오 기업의 대체 자금원은? (Korean-language podcast)
0:00
4:30
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Citeline Podcasts?
This episode is 4 minutes long.
When was this Citeline Podcasts episode published?
This episode was published on August 29, 2025.
Can I download this Citeline Podcasts episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!